PROM1 and small cell lung carcinoma: In thenear future, it is our hope to both expand our investigations intoradiotheranostics for SCLC by working to create CD133-targeted probeswith more rapid in vivo profiles and pursue otherpromising targets for the nuclear imaging and radiopharmaceuticaltherapy of this devastating disease.